Evommune Funding & Investors
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.
evommune.comTotal Amount Raised: $153,000,000
Evommune Funding Rounds
Series B
$7,500,000
Series B Investors
Verition Fund ManagementSeries B
$50,000,000
Series B Investors
Arix BioscienceAndera PartnersAmplitude VenturesSymBiosisLSP (Life Sciences Partners)Pivotal bioVenture PartnersSeries A
$83,000,000
Series A Investors
Andera PartnersLSP BioVenturesPivotal bioVenture PartnersSeed
$12,500,000
Seed Investors
Pivotal bioVenture Partners
Funding info provided by Diffbot.